文献速递妇科产科

卵巢癌幸存者长期泌尿生殖系统疾病风险:人群队列研究

Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study.
PubMed 文献 · Gynecol Oncol · 2020-02-29

该研究基于犹他州人群数据库,纳入1270例1996-2012年诊断的卵巢癌幸存者及5286名匹配的无癌女性,评估诊断后1-<5年及5年以上泌尿生殖系统疾病风险。结果显示幸存者泌尿系统疾病(HR 2.53,95%CI 2.12-3.01)和生殖器官疾病(HR 1.88,95%CI 1.57-2.27)风险显著增加,且部分风险持续至5年以上。

要点

  • 卵巢癌幸存者诊断后1-<5年泌尿系统疾病风险为一般人群的2.53倍。
  • 生殖器官疾病风险同期增加至1.88倍,部分疾病风险持续5年以上。
  • 需关注急性肾衰竭、慢性肾病、肾结石、肾积水等长期并发症。

核心结论

  • 卵巢癌幸存者长期面临多种泌尿生殖系统疾病风险增加。

研究设计与样本

  • 基于犹他州癌症登记和人群数据库的人群队列研究,纳入1270例卵巢癌幸存者和5286名匹配无癌女性。

主要发现

  • 诊断后1-<5年,泌尿系统疾病风险HR 2.53(95%CI 2.12-3.01),生殖器官疾病风险HR 1.88(95%CI 1.57-2.27)。
  • 急性肾衰竭、慢性肾病、肾结石、肾积水、盆腔腹膜粘连和盆腔器官炎症性疾病风险增加。
  • 部分疾病风险在诊断后5年以上仍持续增加。

临床怎么用

  • 卵巢癌治疗完成后应长期监测泌尿生殖系统并发症,尤其肾脏和盆腔疾病。

局限性

  • 研究基于特定人群数据库,结果外推需谨慎;未报告其他潜在混杂因素控制情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While genitourinary complications during treatment for ovarian cancer are well-known, long-term adverse outcomes have not been well characterized. The number of ovarian cancer survivors has been increasing. The aim of this study was to investigate long-term adverse genitourinary outcomes in a population-based cohort. METHODS: We identified a cohort of 1270 ovarian cancer survivors diagnosed between 1996 and 2012 from the Utah Cancer Registry, and 5286 cancer-free women were matched on birth year and state from the Utah Population Database. Genitourinary disease diagnoses were identified through ICD-9 codes from electronic medical records and statewide healthcare facilities data. Cox proportional hazards models were used to estimate hazard ratios (HR) for genitourinary outcomes at 1 to <5 years and 5+ years after ovarian cancer diagnosis. RESULTS: Ovarian cancer survivors had increased risks for urinary system disorders (HR: 2.53, 95% CI: 2.12-3.01) and genital organ disorders (HR: 1.88, 95% CI: 1.57-2.27) between 1 and <5 years after cancer diagnosis compared to the general population cohort. Increased risks were observed for acute renal failure, chronic kidney disease, calculus of kidney, hydronephrosis, pelvic peritoneal adhesions, and pelvic organ inflammatory conditions. Increased risks of several of these diseases were observed 5+ years after cancer diagnosis. CONCLUSIONS: Ovarian cancer survivors experience increased risks of various genitourinary diseases compared to women in the general population in the long-term. Understanding the multimorbidity trajectory among ovarian cancer survivors is important to improve clinical care after cancer treatment is completed.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chang CP, Chen Y, Blackburn B, et al. Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecol Oncol. 2020. PMID: 32122688. doi:10.1016/j.ygyno.2020.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。